Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Regulatory News (MPH)

  • There is currently no data for MPH

Marchpole Update

23 Mar 2005 07:00

Marchpole Holdings PLC23 March 2005 23 March 2005 Marchpole Holdings plc ("the Company") Marchpole Update Marchpole Holdings plc, which designs, produces and sells high quality clothingand accessories for six world class brands (Yves Saint Laurent, Boateng,Jean-Charles de Castelbajac ("JCC") and Jean-Charles de Castelbajac / Rossignol,Emmanuel Ungaro and Ungaro. The Company is pleased to announce that its differences with Ozwald Boateng andhis company have been resolved by the current court proceedings and aninjunction has been granted preventing Bespoke Couture Limited from sellingsuits and other items through a discount outlet, established without referenceto the Company. The dispute involved a number of issues. In April 2004 Ozwald Boateng andBespoke Couture alleged breach of contract and threatened termination of itsdiffusion licence with the Company. The allegation was made in respect of theCompany withholding a compensation payment under an agreement first made inOctober 2002 that provided for the termination or conclusion of an O-Z designagreement with Debenhams and subsequent removal of O-Z stock, which the Companyalleged was to take place by 1 September 2003. This agreement was concludedseparately to the main licence contract. As stock did exist at this time theCompany withheld payments and sought an amicable conclusion. Under threat ofcourt proceedings Bespoke Couture withdrew its first threat to terminate andwhen a second threat was made this was successfully resisted with BespokeCouture having to withdraw its threat and costs were awarded to the Company.Following recent court proceedings it was found that the Company should make thecompensation payment from March 2004, the date that the O-Z product was finallyremoved from Debenhams, a position which the Company has always been prepared toconsider. During November 2004, the Company became aware of an Ozwald Boateng discountoutlet operating at Bicester Village. the Company contended that this was inbreach of the main licence agreement and this was confirmed by yesterday'sjudgment. The injunction granted, as Bespoke Couture has accepted, will meanthat Bespoke Couture will have to close this outlet. Costs were awarded reflecting success on the various issues with the detailedfinancial implications to be determined at a later date. Greg Tufnell, Chief Executive commented: "Throughout this process we have always sought to reassure our shareholders thatthese issues would not impact our main licence agreement nor our financialprojections. The judgment handed down is consistent with these reassurances andI now look forward to focusing on the successful platform Marchpole has builtfor the Boateng brand" For further information contact: Marchpole Greg Tufnell - Chief Executive 020 7908 7700Michael Morris - Executive Director Shore Capital Alex Borrelli 020 7408 4090 Buchanan Tim Thompson / Nicola Cronk 020 7466 5000 Notes to editors: In September this year, Marchpole announced strong interim results for the sixmonths ended 2 October 2004, with operating profit up 194% to £2.6 million(2003: £0.9m) on increased turnover of £15.7 million (2003 : £8.0 million). This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th May 20177:00 amRNSInitiation of BPS-804 Phase 2b study
28th Apr 20173:37 pmRNSHolding(s) in Company
28th Apr 201712:53 pmRNSHolding(s) in Company
28th Apr 201710:05 amRNSHolding(s) in Company
26th Apr 20177:00 amRNSConversion of loan note and issue of equity
24th Apr 20176:07 pmRNSHolding(s) in Company
5th Apr 20177:00 amRNSGrant of Options and Awards
3rd Apr 20177:00 amRNSResults of Placing
31st Mar 20175:54 pmRNSResults of Placing
29th Mar 201712:30 pmRNSProposed Placing
15th Mar 20177:00 amRNSPosting of Annual Report and Notice of AGM
7th Mar 20177:00 amRNSPositive recommendation for BGS-649 Phase 2b trial
27th Feb 20177:00 amRNSPreliminary Results
20th Feb 20177:00 amRNSEMA Adaptive Pathways programme accepts BPS-804
23rd Jan 20177:05 amRNSPresentation at Shares Spotlight Evening
23rd Jan 20177:00 amRNSThree abstracts accepted for ATS Meeting
12th Jan 20177:01 amRNSDirectorate update
5th Jan 201712:00 pmRNSMereo BioPharma to Present at Biotech Showcase
12th Dec 20167:00 amRNSBusiness Update
7th Nov 20167:10 amRNSAppointment of Chief Financial Officer
3rd Nov 20167:00 amRNSPositive Phase 1 interaction study with BCT-197
5th Oct 20167:00 amRNSDirectorate Change
16th Sep 20167:00 amRNSHalf-year Report
9th Aug 20164:04 pmRNSNotice of Results
18th Jul 20161:25 pmRNSResult of AGM
30th Jun 20167:00 amRNSBPS-804 granted EU orphan drug status
24th Jun 201612:47 pmRNSNotice of AGM
9th Jun 20161:17 pmRNSDirector/PDMR Shareholding
9th Jun 20168:01 amRNSFirst Day of Dealings on AIM
10th Nov 20086:21 pmRNSFurther re financial position
4th Nov 20083:01 pmRNSStatement re suspension
4th Nov 20083:00 pmRNSSuspension
23rd Oct 20084:35 pmRNSHolding(s) in Company
23rd Oct 20082:25 pmRNSAGM Statement
2nd Oct 20083:14 pmRNSHolding(s) in Company
23rd Sep 200810:02 amRNSNotice of AGM
1st Sep 200810:06 amRNSHolding(s) in Company
29th Aug 20083:20 pmRNSResult of GM and Interim Mana
26th Aug 200810:13 amRNSHolding(s) in Company
19th Aug 20082:22 pmRNSHolding(s) in Company
14th Aug 20084:23 pmRNSHolding(s) in Company
13th Aug 200811:00 amRNSDirectorate Change
8th Aug 200811:14 amRNSHolding(s) in Company
8th Aug 200811:03 amRNSHolding(s) in Company
7th Aug 20084:46 pmRNSHolding(s) in Company
6th Aug 20084:41 pmRNSSecond Price Monitoring Extn
6th Aug 20084:36 pmRNSPrice Monitoring Extension
6th Aug 20083:17 pmRNSDirector/PDMR Shareholding
6th Aug 20087:08 amRNSFundraising and New Board App
6th Aug 20087:05 amRNSNew Joint Venture

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.